Previous close | 12.41 |
Open | 12.59 |
Bid | 12.11 x 500 |
Ask | 12.21 x 400 |
Day's range | 11.84 - 12.59 |
52-week range | 4.94 - 20.52 |
Volume | |
Avg. volume | 1,794,382 |
Market cap | 586.759M |
Beta (5Y monthly) | 1.47 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cardlytics fair value estimate is US$19.74 Current share price...
On April 1, 2024, CEO Karim Temsamani of Cardlytics Inc (NASDAQ:CDLX), a company specializing in purchase intelligence to make marketing more relevant and measurable, sold 32,718 shares of the company.
Cardlytics Inc (NASDAQ:CDLX), a company specializing in purchase intelligence, enabling marketers to make more informed business decisions and effectively measure and optimize advertising spend, has reported an insider sale according to a recent SEC filing.